March 2026
Anxiety
What March 2026's 25 new studies found, synthesized from the papers below. All Anxiety research →
The synthesis
Synthesized from 11 studies in the library · AI-generated, grounded in the abstracts below
Found by searching the library for Anxiety, generalized anxiety disorder, GAD, panic disorder, anxiety disorder, then ranked by relevance.
Research in March 2026 indicates that mindfulness-based interventions, breathwork, and Transcendental Meditation can reduce anxiety symptoms, with effect sizes ranging from small (school-based MBIs, g=0.11) to medium/large (breathwork in paramedics), though evidence is limited by small samples, short follow-ups, and low certainty. Psychedelic research shows moderate-to-large reductions in death anxiety (d=0.70) and age-dependent effects on anxiety, but these findings are based on small meta-analyses and cross-sectional surveys. Overall, the evidence is promising but preliminary, with notable gaps in long-term durability and diverse populations.
Evidence by study
Direction is which way each study's own result points, not our rating of the study. All 25 matching studies were reviewed; the 11 that directly address the question are shown here.
What the directions mean
- Supports:
- the study found the intervention worked, or its hypothesis held.
- Opposes:
- it found the opposite, no benefit or a harm.
- No effect:
- no significant difference either way.
- Mixed:
- effects in both directions within the same study.
- Unclear:
- the abstract does not report a direction.
| Study | Design | Sample size | Direction | Finding |
|---|---|---|---|---|
| A Brief Intervention for the Treatment of Anxiety in Pregnancy: A Pilot Randomized Controlled Trial (The TAP Study). 2026 | pilot randomized controlled trial | 69 | Supports | MAPP plus treatment as usual significantly reduced anxiety symptoms compared to treatment as usual alone. |
| Frequent loving kindness meditation relates to lower anxiety in long term practitioners through higher self compassion and cognitive flexibility. 2026 | observational study | Supports | Frequent loving kindness meditation relates to lower anxiety through higher self-compassion and cognitive flexibility. | |
| An Umbrella Review of Meta-analyses of School-Based Mindfulness Based Interventions (MBIs) 2026 | umbrella review | 28910 | Supports | School-based MBIs are associated with very small improvements in anxiety (g=0.11) but not depression. |
| Feasibility and Acceptability of Transcendental Meditation for Indian Healthcare Professionals in a Tertiary Care Hospital: A Pilot Randomized Controlled Feasibility Trial 2026 | randomized controlled trial | 76 | Mixed | Transcendental Meditation was feasible and acceptable, with preliminary improvements in anxiety, burnout, and well-being but not in perceived stress. |
| Examining the implementation of a mindfulness-based intervention for anxiety: A mixed-method, single-case study investigation 2026 | single-case study | 1 | Supports | A 6-week mindfulness-based intervention reduced anxiety, stress, depression, and intolerance of uncertainty, and increased mindfulness and resilience in one individual. |
| Examining the Effectiveness of Breathwork to Improve Resilience and Psychological Wellbeing While Reducing Anxiety, Depression, Stress, and Insomnia in Paramedicine Students: A Single‐Blind Randomised Controlled Trial 2026 | randomized controlled trial | 98 | Supports | The A52 Breath Method significantly reduced anxiety, depression, and stress, and enhanced resilience compared to controls, with medium to large effect sizes. |
| Effective doses of esketamine oral or esketamine intranasal for the prevention of preoperative anxiety in pediatric patients: A randomized double-blind dose-finding trial 2026 | randomized controlled trial | Supports | Single-dose esketamine, administered orally or intranasally, effectively mitigates preoperative anxiety in children, with specific ED95 values for each route. | |
| Confronting mortality: A meta-analysis and systematic review of psychedelic experiences and death anxiety 2026 | systematic review and meta-analysis | 8 | Supports | Psychedelic administration is associated with a moderate-to-large reduction in death anxiety (d=0.70), with stronger effects in clinically controlled settings. |
| Age moderates the relationship between psychedelics use and mental health in naturalistic settings 2026 | cross-sectional survey | 1088 | Mixed | Classic psychedelic use was linked to lower anxiety in younger adults, but this effect diminished with age and reversed for anxiety in older participants. |
| Exploring associations between connectedness and death anxiety following a psychedelic experience 2026 | retrospective cross-sectional survey | 106 | Supports | Increases in connectedness to self, others, and the world were each associated with reduced fear of death, but only connectedness to self and others was related to lower death avoidance. |
| A repeated low-dose regimen of MDMA has transient next-day effects on locomotor activity, anxiety-like behavior, and brain serotonin levels, with no effect on anhedonia-like behavior, in both female and male rats 2026 | experimental study | Opposes | Repeated low-dose MDMA produced transient mild anxiety-like behavior and reduced serotonin in the nucleus accumbens one day after exposure, with no lasting effects at 15 days. |
MAPP plus treatment as usual significantly reduced anxiety symptoms compared to treatment as usual alone.
pilot randomized controlled trial Sample size: 69
Frequent loving kindness meditation relates to lower anxiety through higher self-compassion and cognitive flexibility.
observational study
School-based MBIs are associated with very small improvements in anxiety (g=0.11) but not depression.
umbrella review Sample size: 28910
Transcendental Meditation was feasible and acceptable, with preliminary improvements in anxiety, burnout, and well-being but not in perceived stress.
randomized controlled trial Sample size: 76
A 6-week mindfulness-based intervention reduced anxiety, stress, depression, and intolerance of uncertainty, and increased mindfulness and resilience in one individual.
single-case study Sample size: 1
The A52 Breath Method significantly reduced anxiety, depression, and stress, and enhanced resilience compared to controls, with medium to large effect sizes.
randomized controlled trial Sample size: 98
Single-dose esketamine, administered orally or intranasally, effectively mitigates preoperative anxiety in children, with specific ED95 values for each route.
randomized controlled trial
Psychedelic administration is associated with a moderate-to-large reduction in death anxiety (d=0.70), with stronger effects in clinically controlled settings.
systematic review and meta-analysis Sample size: 8
Classic psychedelic use was linked to lower anxiety in younger adults, but this effect diminished with age and reversed for anxiety in older participants.
cross-sectional survey Sample size: 1088
Increases in connectedness to self, others, and the world were each associated with reduced fear of death, but only connectedness to self and others was related to lower death avoidance.
retrospective cross-sectional survey Sample size: 106
Repeated low-dose MDMA produced transient mild anxiety-like behavior and reduced serotonin in the nucleus accumbens one day after exposure, with no lasting effects at 15 days.
experimental study
Points of agreement
- Mindfulness-based interventions consistently reduce anxiety symptoms across diverse populations, including pregnant persons, school children, and individuals with anxiety.
- Psychedelic experiences are associated with reductions in death anxiety, with mystical experiences playing a key role.
- Breathwork and Transcendental Meditation show preliminary efficacy in reducing anxiety in specific populations.
Conflicts
- Psychedelic use is associated with lower anxiety in younger adults but reversed for anxiety in older participants, indicating age-dependent effects.
- MDMA administration in rats induced transient anxiety-like behavior, contrasting with the anxiolytic effects of psychedelics in human studies.
Gaps
- Durability of effects beyond short-term follow-up is largely unstudied.
- Most studies have small sample sizes and lack blinding, especially for mindfulness and breathwork interventions.
- Age-stratified research is needed to clarify the moderating role of age in psychedelic effects on anxiety.
- Long-term safety and efficacy of psychedelics in adolescents and older adults remain unstudied.